Advertisement · 728 × 90

Posts by RESIST-TB

Preview
Urban and rural prevalence of tuberculosis in low- and middle-income countries: A systematic review and meta-analysis In a systematic review and meta-analysis, Seyed Alireza Mortazavi and colleagues investigate urban versus rural differences in adult pulmonary tuberculosis prevalence between 2000 and 2024 in 26 low- ...

In meta-analysis of national and subnational #TB prevalence surveys, we found that between 2000-2024, tuberculosis epidemics are rapidly urbanising.

doi.org/10.1371/jour...

@plosmedicine.org
@uofgshw.bsky.social
@kchorton.bsky.social

2 weeks ago 4 5 0 0

Work in progress: sars-2 clearly increases risk of tuberculosis activation in central Ontario, on a timeline that is consistent with T cell injury. It does not impact risk of non tuberculous mycobacterial infections

More follows

2 weeks ago 118 48 3 2

🚨 BREAKING: Scientists develop an intranasal DNA vaccine targeting drug-resistant tuberculosis a potential game-changer in global TB control.

This could improve prevention and strengthen protection against one of the world’s most dangerous infectious diseases.

2 weeks ago 274 56 4 8
Promo - Course on DR-TB: from Clinical to Programmatic, with Dr Ignacio Monedero
Promo - Course on DR-TB: from Clinical to Programmatic, with Dr Ignacio Monedero YouTube video by International Union Against Tuberculosis and Lung Disease

The Union is offering a free and accessible course created for clinicians and program managers who are working or planning to work with DR-TB. Learn more here! www.youtube.com/watch?v=J0h-...

2 weeks ago 0 0 0 0
Preview
Trials to watch: Phase III TB vaccines and MDR-TB treatments GlobalData epidemiologists project TB cases across the 16 major markets to reach 4.5 million by 2033.

After years without much advancement in new TB drug trials, a vaccine and two treatments are progressing through late-stage studies. This article highlights a few current trials that could have major impacts on TB globally. www.clinicaltrialsarena.com/features/tri...

2 weeks ago 1 0 0 0
Stay up-to date on this month's TB developments!

Check out our latest monthly newsletter and subscribe in the top left corner! mailchi.mp/1d96f24b9449...

2 weeks ago 0 0 0 0
Post image

SAVE THE DATE: Ahead of the Data? The NC‑009 TB Trial Results and a Predictive Translational Model.

We hope you can join us for our next webinar 'Ahead of the Data? The NC‑009 TB Trial Results and a Predictive Translational Model' on April 14th at 11am ET!

4 weeks ago 1 0 0 0

Our analysis of #TB exposure and transmission patterns is now in @pnas.org. @petedodd24.bsky.social and I found a majority of TB transmission globally is attributable to contact with adult men, while contributions to transmission by age are more variable across regions.
www.pnas.org/doi/10.1073/...

1 month ago 10 8 0 0
Advocates in front of Massachusetts congressional offices

Advocates in front of Massachusetts congressional offices

Advocates in front of Massachusetts congressional offices

Advocates in front of Massachusetts congressional offices

Advocates at Union Pub in Washington DC

Advocates at Union Pub in Washington DC

Advocates in front of Massachusetts congressional offices

Advocates in front of Massachusetts congressional offices

We Are TB’s Kelly was in DC on #TBHillDay ! Thanks to offices of @repauchincloss.bsky.social @warren.senate.gov @trahan.house.gov & Rep. Lynch for meeting w/ Kelly, @stoptbusa.bsky.social and the @tbfighters.org ! ALSO: Check out Kelly on this TB ED Talk TONIGHT!! www.youtube.com/live/g4gE2bp...

1 month ago 11 6 0 0
Max O'Donnell | Resisttb

RESIST-TB is excited to share that Dr. Max O'Donnell is joining our steering committee! An Associate Professor of Medicine & Epidemiology at Columbia University Irving Medical Center, Max leads a multidisciplinary research program focused on global health. Read here! www.resisttb.org/max-o-donnell1

1 month ago 0 0 0 0
Advertisement

Researchers from the University of Virginia have received a grant from the Pittsfield Anti-Tuberculosis Association to create a global, web-based resource to further support nurses that are caring for individuals with DR-TB. Read more here! mcusercontent.com/d8f4400bf69c...

1 month ago 0 0 0 0

A 6month oral treatment for rifampicin-resistant TB was more effective and more cost effective compared to the longer therapies/medications currently used in India. An economic evaluation found that BPaL-based regimens are more likely to be cost effective or cost saving. www.ndtv.com/health/6-mon...

1 month ago 0 0 0 0
Stay up-to date on this month's TB developments!

Check out our latest monthly newsletter and subscribe in the top left corner! mailchi.mp/a2a84c4f7b72...

1 month ago 0 0 0 0
Preview
Diagnosing tuberculosis in four hours instead of three weeks In Lithuania, the number of people suffering from tuberculosis is among the highest in the European Union. Kaunas’ hospital has been modernised thanks to European funding and is aiming to curb the disease thanks in part to a new genetic test that can diagnose the disease in just four hours.

Diagnosing tuberculosis in four hours instead of three weeks

1 month ago 21 11 0 0
Preview
4 Months Trapped in a Hospital for an Obsolete Way of Treating Their Disease

one type of foreign aid that developing countries are having trouble finding another way to fund is testing for diseases, like whether the TB responds to antibiotics, is multi-drug resistant (MDR), or extremely drug resistant (XDR); and stipends for health care workers to test/treat diseases at home

2 months ago 2 2 0 0
Preview
AI detects tuberculosis on photos of chest x-rays Mobile phone-based analog radiographic image analysis could represent an easily implementable tool.

Health professionals can now use photographing film x-rays to create digital files and then give those files to AI. This new diagnostic tool can improve the detection/diagnosis of TB on chest x-rays in areas where resources and radiologists may be scarce. www.auntminnie.com/clinical-new...

2 months ago 0 0 0 0
Stay up-to date on this month's TB developments!

Check out our latest monthly newsletter and subscribe in the top left corner!
mailchi.mp/7259f8767b81...

2 months ago 0 0 0 0
Advertisement
Preview
Diet and nutrition status of adult multidrug-resistant tuberculosis cases, household controls, and community controls in Mumbai, India India accounts for the largest national proportion of global multi-drug resistant (MDR-TB) cases and TB mortality. However, evidence on the role of diet and nutrition in MDR-TB infection remains limit...

A new study from Mumbai published in PLOS Global Public Health shows adults with MDR‑TB face severe nutrition deficits—far worse than household or community controls. It presents a strong case for integrating nutrition into TB care.

journals.plos.org/globalpublic...

2 months ago 10 4 0 0
Preview
S.F. private school cancels in-person classes amid active tuberculosis cases After a week of remote instruction at Archbishop Riordan High School, only students who have completed their tuberculosis testing will be allowed to return to campus.

“Cases of active tuberculosis in San Francisco increased by 35% from 2023 to 2024 — more than three times the national rate and twice the California rate…”

2 months ago 38 13 0 2
Post image

Predicted Preferences for Tuberculosis Point-of-Care Tests among Tuberculosis-Affected Individuals in Five High Burden Countries

✅ Just Accepted
🔗 https://bit.ly/3Lyvb6u

3 months ago 3 4 0 1
Stay up-to date on this month's TB developments!

Check out our latest monthly newsletter and subscribe in the top left corner!
mailchi.mp/6a69e810f2f1...

3 months ago 0 0 0 0
Preview
This new, one-two punch could knock out drug-resistant TB - News Tuberculosis is both curable and preventable, yet each year, it still kills more people than any other infectious disease. One reason is that current treatments hinge on rifampicin, an antibiotic that...

A recent study has demonstrated that rifampicin when paired with a second compound called AAP-SO2, becomes a more powerful treatment in both suppressing TB resistance and targeting the dormant TB bacteria that other medications struggle to attack. Read more here! www.rockefeller.edu/news/38777-t...

3 months ago 1 0 0 0
Preview
New vaccines could help us consign tuberculosis to history: here’s how we can do it New tuberculosis vaccine candidates are currently going through the final stages of clinical trials. We need to work together to ensure they reach the millions who need them quickly and effectively.

TB claims 1.2 million lives each year. New vaccine candidates currently in late-stage trials may help reduce this toll, but only if countries can access them without delay.

Gavi’s CEO Dr Sania Nishtar sets out the path forward: bit.ly/4ikaLtG

4 months ago 2 2 0 0
A quote card with a light tie dye background. "No disease, especially tubrculosis, should be about capital. - Dr. Edward Robitzek in The Black Angels by Maris Smilios"

A quote card with a light tie dye background. "No disease, especially tubrculosis, should be about capital. - Dr. Edward Robitzek in The Black Angels by Maris Smilios"

Wealth has a large impact on quality of care, or even if one gets care, as individuals like Dr. Robitzek saw in his personal and professional life. How does income impact a person’s experience with TB, both today and in the past? #TBReaders

3 months ago 19 6 1 0
Preview
Essential redundancies fuel Mycobacterium tuberculosis adaptation to the host Redundancy in biology is, at a glance, counterintuitive because if the function of two gene products completely overlaps then, throughout the course of evolution, one of the genes will likely accumula...

Mycobacterium tuberculosis is an outlier in many ways. One of them is keeping a high degree of functional redundancy despite its obligate pathogen lifestyle. In this review, we reflect on the biological meaning of M. tuberculosis functional redundancies.

journals.plos.org/plospathogen...

4 months ago 35 14 1 1
Preview
Phase 2 data suggest new drug could unlock shorter TB treatment

Data from a phase II trial showed that sorfequiline had greater activity against drug-susceptible TB compared to existing treatments at 8 weeks in addition to a more favorable safety profile, giving hope for a new, shorter treatment option. Read more here!
www.cidrap.umn.edu/tuberculosis...

4 months ago 0 0 0 0
1.3 Drug-resistant TB 1.3 Drug-resistant TB

MDR-TB has been decreasing globally since 2015, with the estimated number of people who have developed MDR-TB in 2024 at 390,000. Read more about MDR-TB trends globally in the WHO Global Tuberculosis Report 2025: 1.3 Drug-Resistant TB.
www.who.int/teams/global...

4 months ago 2 0 0 0
Advertisement
Stay up-to date on this month's TB developments!

Check out our latest monthly newsletter and subscribe in the top left corner!
mailchi.mp/463e0f0397ad...

4 months ago 0 0 0 0
Preview
Everything Is Tuberculosis John Green, the #1 bestselling author of The Anthropocene Reviewed and a passionate advocate for global healthcare reform, tells a deeply human story illuminating the fight against the world’s deadlie...

TB is making a comeback.
Malnutrition and overcrowding create ideal conditions for tuberculosis to spread. It often takes years for symptoms to appear. Meanwhile, the disease spreads. There is no vaccine in the US. See John Green’s book, Everything is Tuberculosis
everythingistb.com

4 months ago 6 3 0 0
Preview
Tuberculosis outbreak hits Newfoundland and Labrador Health officials in Newfoundland and Labrador are warning about an outbreak of tuberculosis within the Labrador Inuit Settlement Area.

Tuberculosis outbreak hits Labrador weeks after Inuit group decried funding loss

4 months ago 3 2 0 1